Safety of biologics during pregnancy in women with immune-mediated inflammatory diseases

Research output: Types of ThesisDoctoral ThesisInternal

Abstract

The aim of this dissertation is to fill in the knowledge gaps on the use of biologics during pregnancy in women suffering from immune-mediated autoimmune diseases (IMIDs). To address this aim we used different information sources: for retrospective studies data was assembled from European Medicines Agency’s (EMA) EudraVigilance database; for prospective studies, patients were included from the Preconceptional Counselling in Active Rheumatoid Arthritis (PreCARA) cohort at Erasmus Medical Center in Rotterdam, the Netherlands.
Original languageEnglish
Awarding Institution
  • Erasmus University Rotterdam
Supervisors/Advisors
  • Hazes, Johanna M.W., Supervisor
  • van Puijenbroek, Eugene, Supervisor
  • Dolhain, Radboud, Supervisor
  • Crijns, HHM, Co-supervisor
Award date23 Feb 2023
Place of PublicationRotterdam
Print ISBNs978-94-6361-795-6
Publication statusPublished - 23 Feb 2023

Fingerprint

Dive into the research topics of 'Safety of biologics during pregnancy in women with immune-mediated inflammatory diseases'. Together they form a unique fingerprint.

Cite this